Bioperfectus Monkeypox Virus PCR Kit to Support Testing Across Africa

Company news

June 28, 2022, Shanghai, China— Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) Deputy General Manager Mr. TUNC MERT SAYIN addressed the opening ceremony of the Training Workshop on Monkeypox Diagnosis Using Real Time PCR Technique held by Africa Centers for Disease Control and Prevention (*hereinafter refer to as Africa CDC), African Union in collaboration with Nigeria Centre for Disease Control (Nigeria CDC) and African Society for Laboratory Medicine (ASLM).



With the monkeypox virus cases resurging globally, Africa CDC is actively working on highlighting the PCR technique diagnosis among member countries. The Training Workshop on Monkeypox Diagnosis Using Real Time PCR Technique is part of the Africa CDC daily routines, which aim to give technical training to the laboratorian professionals and enhance the local testing capacity against infectious diseases.


During the speech, Bioperfectus Deputy General Manager of International Sales & Marketing Division, Mr. TUNC MERT SAYIN, said, “As a response to the current Monkeypox outbreak, Bioperfectus delivered Monkeypox Virus Real Time PCR Kits to Africa CDC to be a supportive part of testing and tracing across the region. In the meantime, we would like to extend our appreciation to Africa CDC for having us for the opening speech of the valuable workshop.”


Bioperfectus, a public listed company on Shanghai Stock Exchange, is specialized in molecular diagnostics and has been providing infectious disease testing solutions since 2010. The world faces more threats and challenges of infectious diseases than ever. We have been actively providing solutions, increasing awareness, and empowering the knowledge and skills of frontline healthcare professionals globally.


View the full agenda of the workshop by clicking here>>


About Bioperfectus


Bioperfectus, a publicly listed company on Shanghai Stock Exchange (SSE:688399), has been a leading molecular diagnostic solution provider specializing in infectious diseases since 2010. With headquarters in Jiangsu, and subsidiaries in Shanghai, Beijing, Xi'an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in the molecular diagnostics market with our products ranging from real-time PCR kits, nucleic acid extraction systems, rapid tests, and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream of creating a healthier future for our next generations. For more information, please follow us on LinkedIn or visit


About Africa CDC


Africa CDC is a specialized technical institution of the African Union established to support public health initiatives of Member States and strengthen the capacity of their public health institutions to detect, prevent, control, and respond quickly and effectively to disease threats. To learn more, please visit


Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.


Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.


Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).